Evid Invest
Who owns PCSAWhat PCSA owns — n/a

Who owns Processa Pharmaceuticals, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of PCSA from SEC Form 13F filings across 12 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 12 institutions disclosed 255,549 shares of Processa Pharmaceuticals, Inc. worth $498,316 — about 9.3% of shares outstanding; the largest disclosed holder is Connective Capital Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

12

13F holders

$498,316

value, 2026 filers

9.3%

of shares outstanding (255,549 sh)

4

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PCSA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1Connective Capital Management, LLC85,274$163,7260.1%3.1%+20.6%
2Stonepine Capital Management, LLC55,000$105,6000.0%2%0.0%
3GEODE CAPITAL MANAGEMENT, LLC22,090$42,4120.0%0.8%-11.3%
4CITADEL ADVISORS LLCNEW21,306$40,9080.0%0.8%new
5XTX Topco LtdNEW13,292$25,5210.0%0.5%new
6JANE STREET GROUP, LLCNEW13,264$25,4660.0%0.5%new
7VANGUARD CAPITAL MANAGEMENT LLC12,729$24,4400.0%0.5%0.0%
8StoneX Group Inc.NEW11,437$29,6230.0%0.4%new
9VANGUARD FIDUCIARY TRUST CO10,857$20,8450.0%0.4%0.0%
10UBS Group AG7,794$14,9640.0%0.3%+207.9%
11Tower Research Capital LLC (TRC)2,499$4,7980.0%0.1%+172.2%
12JONES FINANCIAL COMPANIES LLLP7$130.0%0%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.